COVID-19 booster effectively prevents severe illness and hospitalization

Credit: CC0 Public Domain

In a new study from the Center for Disease Control and Prevention, researchers found COVID-19 booster vaccinations improve protection against severe illness and hospitalization.

They examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether it was a booster dose or the No. 3 dose for people who are immunocompromised.

The team found the third dose actually decreased COVID-19-associated hospitalizations significantly―more than the two doses alone.

They say much has been learned about the effectiveness of booster vaccinations in the short time they’ve been available.

It is clear that having the No. 3 dose―the additional dose for immunocompromised people or the booster in healthy people―does further improve your protection against hospitalization and severe disease.

Mayo Clinic recommends getting the COVID-19 booster vaccination five months after you’ve completed your last dose of the Moderna or Pfizer vaccine, or two months after the Johnson & Johnson vaccine.

These recommendations also apply to those who were recently infected with COVID-19.

Researchers say that if somebody has had their primary series and they got COVID-19 infection, they should get their COVID-19 booster as long as it’s been five months since their last dose of the messenger RNA (Moderna or Pfizer) vaccine.

People shouldn’t rely on protection from natural immunity alone. It is safer to get COVID-19 protection from getting vaccinated than from getting COVID-19 itself.

That’s because COVID-19 carries risks of severe disease and other complications.

If you care about Covid, please read studies that many COVID-19 survivors suffer from a new disability, and CBD from cannabis may inhibit COVID-19 infection.

For more information about Covid, please see recent studies about wearable air sampler that could detect personal exposure to coronavirus, and results showing two paths toward ‘super immunity’ to COVID-19.

Copyright © 2022 Knowridge Science Report. All rights reserved.